Xeris Biopharma: Potential to Get Development Payments, Plus Low Double-Digit Royalties Based on Future Sales of Xeris Glucagon for Pumps, Pump Systems
Xeris Biopharma:根据用于泵、泵系统的Xeris胰高血糖素的未来销售情况,有可能获得开发报酬,外加低的两位数特许权使用费
Xeris Biopharma: Potential to Get Development Payments, Plus Low Double-Digit Royalties Based on Future Sales of Xeris Glucagon for Pumps, Pump Systems
Xeris Biopharma:根据用于泵、泵系统的Xeris胰高血糖素的未来销售情况,有可能获得开发报酬,外加低的两位数特许权使用费
使用浏览器的分享功能,分享给你的好友吧